Focus on neurologic diseases: a report from the 59th American Academy of Neurology annual meeting.
Rabasseda
Xavier
X
Prous Science, Barcelona, Spain.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D002491:Central Nervous System Agents / Q000627:therapeutic use; D004032:Diet; D006801:Humans; D007167:Immunotherapy; D009422:Nervous System Diseases / Q000628:therapy*; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D002491:Central Nervous System Agents; D017366:Serotonin Receptor Agonists